Skin flaking is a condition where the skin sheds or peels off in small or large pieces. It is usually caused by a loss of moisture in the skin, leading to dryness and irritation. Skin flaking can occur anywhere on the body, but is most common on the face, scalp, hands, and feet.
Patients with cancer undergoing radiation therapy or chemotherapy can experience damage to the skin, causing dryness, irritation, and flaking.
Some targeted therapies that can commonly cause skin toxicities, including flaking skin, include:
EGFR inhibitors:
- Caprelsa® (vandetanib)
- Erbitux® (cetuximab)
- Gilotrif® (afatinib)
- Iressa® (gefitinib)
- Nerlynx® (neratinib)
- Portrazza® (necitumumab)
- Rybrevant® (amivantamab)
- Tarceva® (erlotinib)
- Tagrisso® (osimertinib)
- Tykerb® (lapatinib)
- Vectibix® (panitumumab)
- Vizimpro® (dacomitinib)
VEGF inhibitors:
- Inlyta® (axitinib)
- Cabometyx®, Cometriq® (cabozantinib)
- Votrient® (pazopanib)
- Stivarga® (regorafenib)
- Nexavar® (sorafenib)
- Sutent® (sunitinib)
MEK inhibitors:
- Mekinist® (trametinib)
- Mektovi® (binimetinib)
- Cotellic® (cobimetinib)
mTOR inhibitors:
- Afinitor® (everolimus)
- Torisel® (temsirolimus)
Retinoids:
- Vesanoid® (tretinoin, ATRA)
Treatment options for skin flaking in patients with cancer may include:
- topical moisturizers
- emollients
- barrier creams to soothe and protect the affected skin.
Common medicated creams that are used include ammonium lactate and salicylic acid.
In more severe cases, the causative agent may need to be stopped and use of topical steroids may be necessary.